000 | 01931 a2200517 4500 | ||
---|---|---|---|
005 | 20250516233509.0 | ||
264 | 0 | _c20150123 | |
008 | 201501s 0 0 eng d | ||
022 | _a1097-685X | ||
024 | 7 |
_a10.1016/j.jtcvs.2014.06.087 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLuo, Jun | |
245 | 0 | 0 |
_aTargeting survival pathways to create infarct-spanning bridges of human embryonic stem cell-derived cardiomyocytes. _h[electronic resource] |
260 |
_bThe Journal of thoracic and cardiovascular surgery _cDec 2014 |
||
300 |
_a3180-8.e1 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Video-Audio Media | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Differentiation |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aCytoprotection |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEmbryonic Stem Cells _xdrug effects |
650 | 0 | 4 |
_aGraft Survival _xdrug effects |
650 | 0 | 4 |
_aHeme Oxygenase (Decyclizing) _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aMyocardial Infarction _xmetabolism |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
650 | 0 | 4 |
_aProtoporphyrins _xpharmacology |
650 | 0 | 4 | _aRats, Nude |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aUp-Regulation |
650 | 0 | 4 |
_aVentricular Function _xdrug effects |
700 | 1 | _aWeaver, Matthew S | |
700 | 1 | _aDennis, James E | |
700 | 1 | _aWhalen, Elizabeth | |
700 | 1 | _aLaflamme, Michael A | |
700 | 1 | _aAllen, Margaret D | |
773 | 0 |
_tThe Journal of thoracic and cardiovascular surgery _gvol. 148 _gno. 6 _gp. 3180-8.e1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jtcvs.2014.06.087 _zAvailable from publisher's website |
999 |
_c24196687 _d24196687 |